Is Surgery Always Necessary for Rectal Cancer? Dr. Sandeep Nayak’s Watch-and-Wait Approach Provides Alternatives

When faced with a rectal cancer diagnosis, one of the most common questions patients ask is whether surgery can be avoided. According to Dr. Sandeep Nayak, a leading oncologist in India, the 'watch-and-wait' (W&W) protocol offers a promising alternative for certain patients. However, this approach requires strict follow-up and is not suitable for everyone. Understanding who qualifies and what the process involves is crucial for making an informed decision.

Understanding the Watch-and-Wait Protocol

The Watch-and-Wait (W&W) protocol is an innovative approach to the management of rectal cancer, particularly for those who achieve a clinically complete response (CCR) after undergoing total neoadjuvant therapy. This therapy typically includes a combination of chemotherapy and radiation followed by chemotherapy aimed at shrinking the tumour before surgery. Traditionally, surgery would follow to remove any remaining cancerous tissue. However, the W&W protocol challenges this conventional approach by potentially avoiding surgery altogether if the cancer shows a complete response.

Dr. Nayak explains that the W&W protocol focuses on preserving the patient's quality of life by avoiding the significant morbidity associated with radical surgery. For patients who achieve a complete response to initial therapy, the benefits of avoiding surgery can be substantial. However, this approach requires rigorous follow-up and is not without risks, as the possibility of cancer regrowth remains a concern.

Who Can Opt for Watch-and-Wait?

Not every patient is a candidate for the W&W protocol. Specific criteria must be met to ensure that the approach is both safe and effective:

• Clinical Complete Response (CCR): The primary candidates for W&W are those who achieve a CCR after neoadjuvant chemoradiotherapy (nCRT) or total neoadjuvant therapy (TNT). This means there is no detectable tumour on clinical examination, endoscopy, or imaging studies.
• Near-Complete Response (NCR): Some patients exhibit a near-complete response, where only minimal residual disease is present. These patients may still be considered for W&W depending on the extent and location of the remaining disease, though they require close monitoring.
• Early-Stage Tumors: Patients with early-stage, small tumours may be ideal candidates for W&W, given the higher likelihood of a complete response to initial therapy.
• Advanced Cancer with Comorbidities: Elderly or frail patients, or those with significant comorbidities that make surgery risky, may also be considered for W&W as surgery risks may outweigh benefits.

Patients with recurrent rectal cancer, distant metastasis, or a history of pelvic irradiation generally do not qualify for the W&W protocol. For these patients, the risk of cancer regrowth or spread is too high to justify delaying or avoiding surgery.

Rigorous Follow-Up is Key

For those who qualify, the W&W protocol demands rigorous follow-up to ensure early detection of any recurrence. Dr. Nayak emphasizes that this strict monitoring is essential to the success of the W&W approach, as early detection of any regrowth allows for timely intervention.

The follow-up process typically involves:

• Physical Examinations: Regular physical exams are conducted every three months for the first two years, then every six months for the next three years. During these exams, the healthcare provider assesses the patient for any signs of recurrence, such as changes in the rectal area or new symptoms.
• Endoscopic Assessment: Flexible sigmoidoscopy or colonoscopy is performed every three to six months during the first two years, then every six to twelve months thereafter. These procedures provide a direct visual assessment of the rectum, allowing for early detection of any regrowth.
• Imaging Studies: High-resolution magnetic resonance imaging (MRI) and diffusion-weighted imaging (DWI) monitor the rectum and surrounding tissues. These highly sensitive imaging techniques are typically performed every three to six months in the first two years. They play a crucial role in the precise monitoring required for the W&W protocol.
• CT Scans: Computed tomography (CT) scans of the chest, abdomen, and pelvis may be performed annually to monitor for distant metastasis. This helps ensure that any signs of cancer spread are caught early.

Outcomes and Considerations

While the W&W protocol offers a potential pathway to avoid surgery and its associated complications, it also comes with important considerations:

• Recurrence Rates: Studies have shown that local regrowth occurs in about 20 to 40%% of patients under the W&W protocol. However, these recurrences are often detected early if the patient is on rigorous follow-up schedule and can be treated effectively with salvage surgery. Early detection is crucial to maintaining the protocol’s success.
• Quality of Life: One of the most significant advantages of the W&W approach is the potential improvement in the quality of life. By avoiding or delaying surgery, patients can preserve normal rectal function and avoid complications such as bowel dysfunction or the need for a permanent colostomy.
• Risk of Metastasis: There is a concern that patients on the W&W protocol may have a higher risk of metastatic disease. This potential risk underscores the need for a thorough and individualized discussion with patients about the benefits and risks of this approach.

Comparing Watch-and-Wait with Surgical Treatment

The experience differs significantly between patients who undergo the W&W protocol and those who opt for surgical treatment:

• Surgical Patients:

○       Immediate Surgery: Most patients undergo surgery soon after neoadjuvant therapy, which might involve low anterior resection (LAR) or abdominoperineal resection (APR), depending on the tumor's location.

○       Recovery and Morbidity: Recovery from surgery can be extensive, with potential complications such as infections, anastomotic leaks, and bowel dysfunction.

○       Quality of Life: Many patients may require a temporary or permanent colostomy. However, with advancements in surgical techniques, the need for a permanent colostomy can now be avoided in over 90% of cases by using techniques like intersphincteric resection (ISR).

○       Follow-Up: Follow-up for surgical patients typically involves colonoscopy once in 3 years and CT scan once is a year. The follow up becomes significantly less vigorous.

• Watch-and-Wait Patients:

○       Avoiding Immediate Surgery: Patients avoid the immediate risks and complications associated with major surgery, which can be particularly beneficial for those with other significant health issues.

○       Strict Follow-Up: The follow-up regimen is more rigorous, involving frequent physical exams, endoscopies, and imaging studies to detect any signs of recurrence early. A strict 3 monthly MRI scan, sigmoidoscopy and examination is currently indicated.

○       Quality of Life: By avoiding surgery, patients maintain normal rectal function and avoid the need for a colostomy, significantly improving their quality of life.

○       Recurrence Monitoring: The risk of local regrowth means W&W patients must be vigilant and committed to their follow-up schedule. Early detection of recurrence allows for timely salvage surgery, which can be curative if caught early.

Conclusion

The Watch-and-Wait protocol offers a promising alternative to surgery for select rectal cancer patients, particularly those who achieve a clinically complete response after neoadjuvant therapy. It provides a pathway to avoid or delay surgery, thereby preserving quality of life while maintaining oncological safety. However, it is not suitable for everyone, as the protocol demands rigorous follow-up to ensure early detection and treatment of any recurrence.

If you or a loved one is considering this approach, it is essential to have a detailed discussion with your healthcare team to determine if you fall into the category of patients who can safely avoid surgery and to understand the commitment required for rigorous follow-up. While the W&W protocol can be a viable option, surgery remains the gold standard for many rectal cancer patients, particularly given that modern surgical techniques can now avoid colostomy in over 90% of cases. Dr. Nayak emphasizes the importance of individualized care, ensuring that patients make informed decisions based on their specific situation.

For further information or to discuss whether the Watch-and-Wait protocol is right for you or a loved one, contact us at support@macsclinic.com. Stay updated on the latest advancements in cancer treatment by following our expert analyses and insights.

Disclaimer: This article is part of sponsored content programme. The Tribune is not responsible for the content including the data in the text and has no role in its selection.